Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults

Riociguat, a first-in-class soluble guanylate cyclase stimulator, is approved for the treatment of pulmonary arterial hypertension (PAH), a serious potential complication of human immunodeficiency virus (HIV) infection. This open-label study investigated the pharmacokinetic drug–drug interaction pot...

Descripción completa

Detalles Bibliográficos
Autores principales: DeJesus, Edwin, Saleh, Soundos, Cheng, Sue, van der Mey, Dorina, Becker, Corina, Frey, Reiner, Unger, Sigrun, Mueck, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540510/
https://www.ncbi.nlm.nih.gov/pubmed/30997864
http://dx.doi.org/10.1177/2045894019848644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540510/
https://www.ncbi.nlm.nih.gov/pubmed/30997864
http://dx.doi.org/10.1177/2045894019848644

Ejemplares similares